Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse J Smith

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Plos One|January 14, 2017
Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial SarcomaSatoshi Kawano, Alexandra R Grassian, Masumi Tsuda, et al.
Molecular Cancer Therapeutics|April 22, 2017
Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in <i>MLL</i>-Rearranged LeukemiaCarly T Campbell, Jessica N Haladyna, David A Drubin, et al.
Molecular Cancer Therapeutics|August 25, 2017
EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCLDorothy Brach, Danielle Johnston-Blackwell, Allison Drew, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2009
Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activatorsJean E Bemis, Chi B Vu, Roger Xie, et al.
Plos One|December 11, 2014
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin LymphomasSarah K Knutson, Natalie M Warholic, L Danielle Johnston, et al.
Protein Science : a Publication of the Protein Society|February 26, 2009
Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3Lei Jin, Heidi Galonek, Kristine Israelian, et al.
Journal of Medicinal Chemistry|February 10, 2009
Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activatorsChi B Vu, Jean E Bemis, Jeremy S Disch, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool CompoundLorna H Mitchell, Allison E Drew, Scott A Ribich, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666Kenneth W Duncan, Nathalie Rioux, P Ann Boriack-Sjodin, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo ActivityJohn E Campbell, Kevin W Kuntz, Sarah K Knutson, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Plos One|January 14, 2017
Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial SarcomaSatoshi Kawano, Alexandra R Grassian, Masumi Tsuda, et al.
Molecular Cancer Therapeutics|April 22, 2017
Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in <i>MLL</i>-Rearranged LeukemiaCarly T Campbell, Jessica N Haladyna, David A Drubin, et al.
Molecular Cancer Therapeutics|August 25, 2017
EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCLDorothy Brach, Danielle Johnston-Blackwell, Allison Drew, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2009
Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activatorsJean E Bemis, Chi B Vu, Roger Xie, et al.
Plos One|December 11, 2014
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin LymphomasSarah K Knutson, Natalie M Warholic, L Danielle Johnston, et al.
Protein Science : a Publication of the Protein Society|February 26, 2009
Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3Lei Jin, Heidi Galonek, Kristine Israelian, et al.
Journal of Medicinal Chemistry|February 10, 2009
Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activatorsChi B Vu, Jean E Bemis, Jeremy S Disch, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool CompoundLorna H Mitchell, Allison E Drew, Scott A Ribich, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666Kenneth W Duncan, Nathalie Rioux, P Ann Boriack-Sjodin, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo ActivityJohn E Campbell, Kevin W Kuntz, Sarah K Knutson, et al.
Pageof 4